proteus infections

Summary

Summary: Infections with bacteria of the genus PROTEUS.

Top Publications

  1. Saito R, Okugawa S, Kumita W, Sato K, Chida T, Okamura N, et al. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients. Clin Microbiol Infect. 2007;13:1204-6 pubmed
    ..The majority of ciprofloxacin-resistant P. mirabilis isolates were multiresistant, and ciprofloxacin resistance was associated significantly with previous use of fluoroquinolones and production of extended-spectrum beta-lactamases...
  2. O Hara C, Brenner F, Miller J. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. 2000;13:534-46 pubmed
    ..Many of these organisms are easily controlled, but the advent of newer and more powerful antimicrobial agents has led to some problems of which laboratorians need to be aware...
  3. Endimiani A, Luzzaro F, Brigante G, Perilli M, Lombardi G, Amicosante G, et al. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 2005;49:2598-605 pubmed
    ..mirabilis isolates. Thus, recognition of ESBL-positive strains appears to be critical for the clinical management of patients with systemic P. mirabilis infections...
  4. Jacobsen S, Stickler D, Mobley H, Shirtliff M. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 2008;21:26-59 pubmed publisher
    ..Research focusing on the pathogenesis of CAUTIs will lead to a better understanding of the disease process and will subsequently lead to the development of new diagnosis, prevention, and treatment options. ..
  5. Rozalski A, Sidorczyk Z, Kotełko K. Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev. 1997;61:65-89 pubmed
    ..All these features and factors are described and commented on in detail. The questions important for future investigation of these facultatively pathogenic microorganisms are also discussed...
  6. Kim B, Kim N, Kim M, Kim Y, Woo J, Ryu J. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000). Scand J Infect Dis. 2003;35:98-103 pubmed
    ..Providencia bacteraemia was relatively uncommon and it can be associated with infections other than UTI...
  7. Wu J, Chen H, Ko W, Wu H, Tsai S, Yan J. Prevalence of extended-spectrum beta-lactamases in Proteus mirabilis in a Taiwanese university hospital, 1999 to 2005: identification of a novel CTX-M enzyme (CTX-M-66). Diagn Microbiol Infect Dis. 2008;60:169-75 pubmed
    ..mirabilis...
  8. Pagani L, Migliavacca R, Pallecchi L, Matti C, Giacobone E, Amicosante G, et al. Emerging extended-spectrum beta-lactamases in Proteus mirabilis. J Clin Microbiol. 2002;40:1549-52 pubmed
    ..Analysis of clonal diversity of the ESBL producers suggested different spreading patterns for the two ESBL determinants...
  9. Broomfield R, Morgan S, Khan A, Stickler D. Crystalline bacterial biofilm formation on urinary catheters by urease-producing urinary tract pathogens: a simple method of control. J Med Microbiol. 2009;58:1367-75 pubmed publisher
    ..0 in which catheter encrustation was inhibited. It is suggested that this dietary strategy will be an effective means of controlling catheter encrustation, whichever bacterial species is causing the problem...

More Information

Publications100

  1. Budding A, Ingham C, Bitter W, Vandenbroucke Grauls C, Schneeberger P. The Dienes phenomenon: competition and territoriality in Swarming Proteus mirabilis. J Bacteriol. 2009;191:3892-900 pubmed publisher
    ..Dienes line formation has implications for the physiology of swarming and social recognition in bacteria...
  2. Wang M, Guo Q, Xu X, Wang X, Ye X, Wu S, et al. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother. 2009;53:1892-7 pubmed publisher
    ..qnrC could not be detected by PCR, however, in 2,020 strains of Enterobacteriaceae. A new quinolone resistance gene, qnrC, was thus characterized from plasmid pHS10 carried by a clinical isolate of P. mirabilis...
  3. Kim J, Park Y, Kim S, Kang M, Lee S, Lee K. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital. J Antimicrob Chemother. 2004;54:1144-7 pubmed
    ..To examine the molecular mechanisms involved in the beta-lactam resistance of multidrug-resistant Proteus mirabilis isolates that showed an unusual synergy between imipenem and ceftazidime in a Korean hospital...
  4. Rodriguez C, Radice M, Perazzi B, Castro S, Juárez J, Santini P, et al. [Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins]. Enferm Infecc Microbiol Clin. 2005;23:122-6 pubmed
    ..The aim of this study was to evaluate betalactam resistance within the genus Proteus and characterize the betalactamases responsible for this resistance...
  5. Canton R, Sánchez Moreno M, Morosini Reilly M. [Proteus penneri]. Enferm Infecc Microbiol Clin. 2006;24 Suppl 1:8-13 pubmed
    ..This phenotype resembles the production of an extended spectrum beta-lactamase. Like other Proteus species, P. penneri is resistant to tetracyclines and should be considered resistant to nitrofurantoin...
  6. Rozalski A, Kwil I, Torzewska A, Baranowska M, Staczek P. [Proteus bacilli: features and virulence factors]. Postepy Hig Med Dosw (Online). 2007;61:204-19 pubmed
    ..Below we focus on data concerning the molecular basis of the pathogenicity of Proteus bacilli...
  7. Luzzaro F, Brigante G, D Andrea M, Pini B, Giani T, Mantengoli E, et al. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management. Int J Antimicrob Agents. 2009;33:328-33 pubmed publisher
    ..This is the first report of a rapid spread of CBL-positive P. mirabilis strains endowed with remarkable antimicrobial resistance. Practical methods for CBL detection are needed for the appropriate management of related infections...
  8. Cohen Nahum K, Saidel Odes L, Riesenberg K, Schlaeffer F, Borer A. Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes. Infection. 2010;38:41-6 pubmed publisher
    ..The aim of our study was to determine the risk factors and clinical outcomes of urinary tract infections (UTIs) caused by MDR PM in patients hospitalized in our institution...
  9. Nakano R, Nakano A, Abe M, Inoue M, Okamoto R. Regional outbreak of CTX-M-2 ?-lactamase-producing Proteus mirabilis in Japan. J Med Microbiol. 2012;61:1727-35 pubmed publisher
    ..These findings indicate the rapidly developing problem of treating the species to prevent dissemination of ESBL producers...
  10. Hjelm E, Lundell Etherden I, Mardh P. Ascending urinary tract infections in rats induced by Staphylococcus saprophyticus and Proteus mirabilis. Acta Pathol Microbiol Immunol Scand B. 1987;95:347-50 pubmed
    ..The antibody response to the different organisms was the same either the bacteria were instilled separately or in combination. ..
  11. Cui G, Zhong S, Yang S, Zuo X, Liang M, Sun J, et al. Effects of Taishan Pinus massoniana pollen polysaccharide on the subunit vaccine of Proteus mirabilis in birds. Int J Biol Macromol. 2013;56:94-8 pubmed publisher
    ..mirabilis; induced stronger humoral, cellular and mucosal immunity as compared with WO and PP; and should be developed as a vaccine adjuvant...
  12. Zunino P, Geymonat L, Allen A, Preston A, Sosa V, Maskell D. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection. FEMS Immunol Med Microbiol. 2001;31:113-20 pubmed
    ..These data reinforce the importance of MR/P fimbriae in P. mirabilis UTI although other virulence factors may be necessary for efficient colonisation and development of infection. ..
  13. Nielubowicz G, Smith S, Mobley H. Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection. Infect Immun. 2010;78:2823-33 pubmed publisher
    ..Since we demonstrated a role for ZnuC in zinc transport, we hypothesize that there is limited zinc present in the urinary tract and P. mirabilis must scavenge this ion to colonize and persist in the host...
  14. Stickler D, Hughes G. Ability of Proteus mirabilis to swarm over urethral catheters. Eur J Clin Microbiol Infect Dis. 1999;18:206-8 pubmed
    ..Migration of swarmers along catheters into the bladder could thus initiate Proteus mirabilis catheter-associated infections. ..
  15. Park Y, Lee S, Kim Y, Oh E, Woo G, Lee K. Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis. J Antimicrob Chemother. 2006;57:156-8 pubmed
  16. Pearson M, Rasko D, Smith S, Mobley H. Transcriptome of swarming Proteus mirabilis. Infect Immun. 2010;78:2834-45 pubmed publisher
    ..These data suggest that the consolidation phase is a state in which P. mirabilis prepares for the next wave of swarming...
  17. Phan H, Lehman D. Cerebral abscess complicating Proteus mirabilis meningitis in a newborn infant. J Child Neurol. 2012;27:405-7 pubmed publisher
    ..With this report, the authors illustrate the importance of surveillance neuroradiologic imaging in patients with Proteus meningitis. ..
  18. Lin Y, Tu C, Chen W, Tsai Y, Chen H, Hsu W, et al. An urgent problem of aerobic gram-negative pathogen infection in complicated parapneumonic effusions or empyemas. Intern Med. 2007;46:1173-8 pubmed
    ..001 and p<0.001 respectively). The increasing incidence of infection with aerobic Gram-negative pathogens may cause more critical conditions in complicated parapneumonic effusions or empyemas. ..
  19. Ikeda Y, Fukuoka Y, Motomura K, Yasuda T, Nishino T. Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice. Antimicrob Agents Chemother. 1990;34:94-7 pubmed
    ..vulgaris occurs by the same mechanisms as the in vitro effect and that the high beta-lactamase inducibility and low beta-lactamase stability may account for the paradoxical therapeutic effect of cefmenoxime against P. vulgaris...
  20. McAleer I, Kaplan G, Bradley J, Carroll S. Staghorn calculus endotoxin expression in sepsis. Urology. 2002;59:601 pubmed
    ..This is the first reported case in which endotoxin was demonstrated in stone fragments from a child who died of severe sepsis syndrome after percutaneous staghorn stone manipulation. ..
  21. Wasfi R, Abd El Rahman O, Mansour L, Hanora A, Hashem A, Ashour M. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections. Indian J Med Microbiol. 2012;30:76-80 pubmed publisher
    ..Ciprofloxacin was more effective in killing bacterial cells especially at high antimicrobial concentrations that could be reached in urine levels and can be used in impregenating catheters. ..
  22. Ghosh B, DeSantis M, Kleyner Y, Zak Y. Crossed fused renal ectopia with calculi. J Am Coll Surg. 2008;206:753 pubmed publisher
  23. Lacort Fernández M, Gutiérrez Fernández M, González Rodríguez M, Antuña Braña M, Herrero Fernández S, Espina Angulo M. [Massive pleural empyema caused by pyonephrosis]. An Med Interna. 2001;18:147-8 pubmed
    ..The treatment must include appropriate antibiotic therapy and thoracic drainage, and also the drain of the purulent accumulations at the kidney and perikidney area. ..
  24. McKeag D, Kamal Z, McNab A, Sheorey H. Combined coliform and anaerobic infection of the lacrimal sac. Clin Exp Ophthalmol. 2002;30:52-4 pubmed
    ..In addition, a literature review is presented of the bacteriology of acute dacryocystitis as it applies to this case. Recommendations for the microbiological investigation and management of acute dacryocystitis are made. ..
  25. Rafailidis P, Kapaskelis A, Falagas M. Henoch-Schönlein purpura associated with Proteus mirabilis urinary tract infection. J Am Acad Dermatol. 2008;58:S98-9 pubmed publisher
  26. Mathur S, Suller M, Stickler D, Feneley R. Prospective study of individuals with long-term urinary catheters colonized with Proteus species. BJU Int. 2006;97:121-8 pubmed
  27. Drzewiecka D, Arbatsky N, Kondakova A, Shashkov A, Knirel Y. Structures and serospecificity of threonine-containing O polysaccharides of two clinical isolates belonging to the genus Proteus and their classification into O11 subserogroups. J Med Microbiol. 2016;65:1260-1266 pubmed publisher
    ..mirabilis 25/57 belonging to O11 serogroup so far. O11a is the sixth new serotype found in Proteus spp. strains recently isolated from patients in central Poland. ..
  28. Shaw J. Microbial persistence: a clinical reminder. Am J Orthop (Belle Mead NJ). 2005;34:183-5 pubmed
  29. McCoy A, Liu H, Falla T, Gunn J. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides. Antimicrob Agents Chemother. 2001;45:2030-7 pubmed
    ..These data further support the role of LPS modifications as an elaborate mechanism in the resistance of certain bacterial species to APs and suggest that LPS surface charge alterations may play a role in P. mirabilis swarming motility. ..
  30. Siebor E, Neuwirth C. Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France. J Antimicrob Chemother. 2013;68:1750-6 pubmed publisher
    ..SGI1 variants are widely distributed among P. mirabilis clinical strains and might spread to other commensal Enterobacteriaceae. This would become a serious public health problem. ..
  31. Pearson M, Yep A, Smith S, Mobley H. Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression. Infect Immun. 2011;79:2619-31 pubmed publisher
    ..mirabilis uses glutamate dehydrogenase to monitor carbon-nitrogen balance, and this ability contributes to the pathogenic potential of P. mirabilis in the urinary tract...
  32. Jacobsen S, Shirtliff M. Proteus mirabilis biofilms and catheter-associated urinary tract infections. Virulence. 2011;2:460-5 pubmed publisher
    ..P. mirabilis biofilm research will lead to a better understanding of the disease process and will subsequently lead to the development of new prevention, and treatment options...
  33. Nutahara K, Higashihara E. [Urolithiasis in hemodialysis patients]. Nihon Rinsho. 2004;62 Suppl 6:370-3 pubmed
  34. Drzewiecka D, Zych K, Sidorczyk Z. Characterization and serological classification of a collection of Proteus penneri clinical strains. Arch Immunol Ther Exp (Warsz). 2004;52:121-8 pubmed
    ..The aim of this research was a serological characterization and classification of 57 Proteus penneri clinical strains, isolated from patients from different countries all over the world, into Proteus O serogroups...
  35. Pearson M, Sebaihia M, Churcher C, Quail M, Seshasayee A, Luscombe N, et al. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol. 2008;190:4027-37 pubmed publisher
  36. Runel Belliard C, Leroy S, Delamar A, Moissenet D, Grimprel E. Selective strategy for urethral catheterization in febrile young girls to confirm urinary tract infection diagnosis. Nephron Clin Pract. 2010;116:c235-40 pubmed publisher
  37. Tumialan L, Lin F, Gupta S. Spontaneous bacterial peritonitis causing Serratia marcescens and Proteus mirabilis ventriculoperitoneal shunt infection. Case report. J Neurosurg. 2006;105:320-4 pubmed
    ..marcescens infection of the CNS, intrathecal administration of gentamicin should be strongly considered as part of first-line therapy for S. marcescens infections in VP shunts. ..
  38. Sedlacek M, Suriawinata A, Schoolwerth A, Remillard B. Ciprofloxacin crystal nephropathy--a 'new' cause of acute renal failure. Nephrol Dial Transplant. 2006;21:2339-40 pubmed
  39. Chandrashekara S, Ramesh M, Shobha A, Saravanan Y, Vadiraja H, Navaneeth B, et al. Proteus mirabilis and rheumatoid arthritis: no association with the disease. Clin Rheumatol. 2003;22:268-70 pubmed
    ..The APA levels did not correlate with serum CRP levels. We conclude that P. mirabilis has no pathological or aggravating role in RA. ..
  40. Esposito S, D Errico G, Montanaro C. Oral ciprofloxacin for treatment of acute bacterial pharyngotonsillitis. J Chemother. 1990;2:108-12 pubmed
    ..Ciprofloxacin administered orally at low dosages is highly effective in the treatment of bacterial pharyngotonsillitis and is also well tolerated. ..
  41. Aragón L, Mirelis B, Miro E, Mata C, Gomez L, Rivera A, et al. Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases. J Antimicrob Chemother. 2008;61:1029-32 pubmed publisher
  42. Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K, Betlejewska K, Hryniewicz W. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother. 2001;47:773-80 pubmed
    ..Of all Enterobacteriaceae tested, 38 strains (6.9%) were capable of producing ESBLs. ..
  43. Collarile T, Di Girolamo N, Selleri P, Melidone R. Mucus accumulation and necrosis of the ventral air pouch in a marabou stork (Leptoptilos crumeniferus) with productive rhinitis. J Avian Med Surg. 2013;27:222-6 pubmed
    ..The unique communication between nasal cavities and the ventral air pouch should be considered in future cases of respiratory infection in marabou storks. ..
  44. Milo S, Thet N, Liu D, Nzakizwanayo J, Jones B, Jenkins A. An in-situ infection detection sensor coating for urinary catheters. Biosens Bioelectron. 2016;81:166-172 pubmed publisher
    ..At the present time, there are no effective methods to control these infections or provide warning of impending catheter blockage. ..
  45. Kwiecińska Piróg J, Bogiel T, Gospodarek E. Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods. J Antibiot (Tokyo). 2013;66:593-7 pubmed publisher
    ..Moreover, ciprofloxacin at concentrations equal to 1/4, 1/2 and 1 times their MIC values for particular P. mirabilis strains reduces biofilm formation more efficiently than ceftazidime at the corresponding concentration values. ..
  46. Asmah R, Blankson H, Seanefu K, Obeng Nkrumah N, Awuah Mensah G, Cham M, et al. Trichomoniasis and associated co-infections of the genital tract among pregnant women presenting at two hospitals in Ghana. BMC Womens Health. 2017;17:130 pubmed publisher
    ..There was 20.2% prevalence of TV among the pregnant women presenting at the hospitals, with Gonococci and Proteus infections being statistically significant associated infections.
  47. Wendler H, Falk W. [Epidemiology of purulent meningitis seen in the pediatric department of Graz University between 1946 and 1971 (author's transl)]. Klin Padiatr. 1974;186:87-91 pubmed
  48. Scheid M, Grothusen C, Lutter G, Petzina R. Cutaneo-pericardial fistula after transapical aortic valve implantation. Interact Cardiovasc Thorac Surg. 2013;16:558-9 pubmed publisher
    ..We report here the case of an 86-year old patient with a cutaneo-pericardial fistula after a transapical TAVI procedure...
  49. Hu Y, Cai J, Zhang R, Zhou H, Sun Q, Chen G. Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital. Antimicrob Agents Chemother. 2012;56:2278-82 pubmed publisher
    ..5 kb. In summary, large clonally related isolates of KPC-2-producing P. mirabilis emerged in a Chinese hospital, and qnrD was detected in KPC-producing P. mirabilis for the first time...
  50. Richter G, Smith J, Dornhoffer J. Otogenic cerebellar abscess: a case report. Ear Nose Throat J. 2009;88:E25-8 pubmed
  51. Yong T, Li J. Proteus vertebral osteomyelitis. Int J Rheum Dis. 2009;12:155-7 pubmed publisher
    ..mirabilis may need to be considered in the context of recent urinary tract infection or urological surgery. Therefore biopsy should be undertaken to establish the causative organism and determine appropriate antibiotic susceptibility...
  52. Corvec S, Beyrouthy R, Crémet L, Aubin G, Robin F, Bonnet R, et al. TEM-187, a new extended-spectrum ?-lactamase with weak activity in a Proteus mirabilis clinical strain. Antimicrob Agents Chemother. 2013;57:2410-2 pubmed publisher
    ..mirabilis and for their potential spread to other Enterobacteriaceae due to a lack of sensitive detection methods used in daily practice...
  53. Shikh Bardsiri H, Shakibaie M. Antibiotic resistance pattern among biofilm producing and non producing Proteus strains isolated from hospitalized patients; matter of hospital hygiene and antimicrobial stewardship. Pak J Biol Sci. 2013;16:1496-502 pubmed
    ..Limited number of the isolates could produce strong biofilm that were bearing plasmids. Majority of the biofilm producing isolates were also resistance at least to 4 antibiotics routinely prescribed in our hospital...
  54. Yapo P, Legeais M, Kieffer V, Pefoubou Y, Cottier J, Herbreteau D. [Case No. 6. Primary abscess of the right psoas-iliac compartment caused by Proteus mirabilis in a female patient with NF1]. J Radiol. 2006;87:715-7 pubmed
  55. Richardson G, Links I, Windsor P. Gudair (OJD) vaccine self-inoculation: a case for early debridement. Med J Aust. 2005;183:151-2 pubmed
  56. Tabibian J, Gornbein J, Heidari A, Dien S, Lau V, Chahal P, et al. Uropathogens and host characteristics. J Clin Microbiol. 2008;46:3980-6 pubmed publisher
    ..aeruginosa UTI: 38% of patients with P. aeruginosa UTIs fit this profile. These data may be useful for planning future targeted prophylaxis studies...
  57. Biendo M, Thomas D, Laurans G, Hamdad Daoudi F, Canarelli B, Rousseau F, et al. Molecular diversity of Proteus mirabilis isolates producing extended-spectrum beta-lactamases in a French university hospital. Clin Microbiol Infect. 2005;11:395-401 pubmed
    ..3%) and 12 (26.6%) isolates, respectively. These pulsotypes were considered to represent epidemic strains and spread in various wards of the hospital...
  58. Tez S, Dilmen G, Unsal A, Koktener A, Cimentepe E, Saglam R. Psoas abscess twenty-one years after ipsilateral nephrectomy. Int Urol Nephrol. 2002;34:311-3 pubmed
    ..It was diagnosed by computed tomography and was drained percutaneously with a nephrostomy tube guided by ultrasonography...
  59. Tighe D, Borne J, Kirsch D, Garayburu J. Otogenic cerebellar abscess: an unusual occurrence. Ear Nose Throat J. 2006;85:218, 220 pubmed
  60. Ebringer A, Rashid T. Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection. Clin Dev Immunol. 2006;13:41-8 pubmed
  61. Janda J, Abbott S, Khashe S, Probert W. Biochemical identification and characterization of DNA groups within the Proteus vulgaris complex. J Clin Microbiol. 2001;39:1231-4 pubmed
    ..Overall expression of selected enzymatic and virulence-associated characteristics did not differ significantly among DNA groups...
  62. Burall L, Harro J, Li X, Lockatell C, Himpsl S, Hebel J, et al. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun. 2004;72:2922-38 pubmed
  63. Blanco Blanco J, Ballesté Torralba J. [Local control treatment of bacteria found present in an infected bed sore by means of a hydropolymer dressing with ionic silver]. Rev Enferm. 2009;32:7-14; quiz 64-6 pubmed
    ..The use of systemic antibiotics should be limited to precise indications, considering that today we have at our disposal alternate treatments with topical antibiotics, principally dressings which contain silver...
  64. Chen Y, Wang Y, Wang F, Wang N. Proteus Takayasu's arteritis with unusual intracranial granulomatosis as initial manifestation. Rheumatol Int. 2012;32:2185-8 pubmed publisher
  65. Li X, Rasko D, Lockatell C, Johnson D, Mobley H. Repression of bacterial motility by a novel fimbrial gene product. EMBO J. 2001;20:4854-62 pubmed
    ..mirabilis strain HI4320 is attenuated in the murine model. Our data also indicate that PapX encoded by a pap (pyelonephritis- associated pilus) operon of uropathogenic Escherichia coli is a functional homolog of MrpJ...
  66. Chew Y, Cheong J, Khir A, Brito Mutunayagam S, Prepageran N. Complications of chronic suppurative otitis media: a left otogenic brain abscess and a right mastoid fistula. Ear Nose Throat J. 2012;91:428, 430 pubmed
    ..We describe a rare case of bilateral chronic suppurative otitis media that caused a left temporal lobe abscess and a right mastoid fistula...
  67. Rashid T, Ebringer A. Rheumatoid arthritis is linked to Proteus--the evidence. Clin Rheumatol. 2007;26:1036-43 pubmed
    ..Prospective longitudinal studies with the use of antimicrobial measures in patients with RA are required to establish the therapeutic benefit of this microbe-disease association...
  68. Lane M, Li X, Pearson M, Simms A, Mobley H. Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli. J Bacteriol. 2009;191:1382-92 pubmed publisher
    ..These findings provide evidence to support a mechanism for persistence of fimbriate bacteria under oxygen limitation, which is relevant to disease progression within the oxygen-restricted urinary tract...
  69. Cieślikowski T, Gradecka D, Mielczarek M, Kaca W. Tandem tetramer-based microsatellite fingerprinting for typing of Proteus mirabilis strains. J Clin Microbiol. 2003;41:1673-80 pubmed
    ..This analysis also indicated that it is possible to estimate some phenotypic properties of P. mirabilis clinical isolates solely on the basis of microsatellite fingerprinting...
  70. Perilli M, Segatore B, De Massis M, Franceschini N, Bianchi C, Rossolini G, et al. Characterization of a new extended-spectrum beta-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey. Antimicrob Agents Chemother. 2002;46:925-8 pubmed
    ..Kinetic analysis of TEM-87 revealed extended-spectrum activity against oxyimino cephalosporins (preferentially ceftazidime) and aztreonam. Expression of blaTEM-87 in Escherichia coli decreased the host susceptibility to these drugs...
  71. Bodur H, Colpan A, Gozukucuk R, Akinci E, Cevik M, Balaban N. Venous sinus thrombosis after Proteus vulgaris meningitis and concomitant Clostridium abscess formation. Scand J Infect Dis. 2002;34:694-6 pubmed
    ..After mastoidectomy, repeat cranial MRI demonstrated abscess formation in the venous sinuses. The abscess was drained. Clostridium spp. was isolated from the abscess culture...
  72. Al Kharashi A, Al Kharshi A, Al Faky Y. Endophthalmitis Due to Proteus vulgaris after Pars Plana Vitrectomy with Devastating Outcome. Middle East Afr J Ophthalmol. 2017;24:116-118 pubmed publisher
    ..The isolated microorganism was Proteus vulgaris which has not been reported as causative bacteria of postoperative infections following pars plana vitrectomy...
  73. Cernohorská L, Chvílová E. [Proteus mirabilis isolated from urine, resistance to antibiotics and biofilm formation]. Klin Mikrobiol Infekc Lek. 2011;17:81-5 pubmed
    ..In the rather rare urinary pathogen Proteus mirabilis resistance to antibiotics and ability to form biofilm were studied...
  74. Kalra A, Cooley C, Tsigrelis C. Treatment of endocarditis due to Proteus species: a literature review. Int J Infect Dis. 2011;15:e222-5 pubmed publisher
    ..We report a case of endocarditis due to Proteus mirabilis that was successfully treated with ampicillin and gentamicin, and review the treatment regimens of previously published cases of Proteus endocarditis...
  75. Zunino P, Geymonat L, Allen A, Legnani Fajardo C, Maskell D. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. FEMS Immunol Med Microbiol. 2000;29:137-43 pubmed
    ..mirabilis isolates showed a reactive AtfA band after Western blot analysis using a polyclonal rabbit AtfA antiserum. These data together suggest that ATF does not play a role in P. mirabilis urinary tract infection...
  76. Alamuri P, Löwer M, Hiss J, Himpsl S, Schneider G, Mobley H. Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis. Infect Immun. 2010;78:4882-94 pubmed publisher
    ..AipA and TaaP individually offered advantages to P. mirabilis in a murine model. This is the first report characterizing trimeric autotransporters in P. mirabilis as afimbrial surface adhesins and autoagglutinins...
  77. Palusiak A, Sidorczyk Z. Serological characterization of the core region of lipopolysaccharides of rough Proteus sp. strains. Arch Immunol Ther Exp (Warsz). 2009;57:303-10 pubmed publisher
    ..Using this kind of material enables identifying fragments of the Proteus LPS core region that might be involved in cross-reactions. To date only a few similar epitopes have been established for the genus Proteus...
  78. Armbruster C, Hodges S, Mobley H. Initiation of swarming motility by Proteus mirabilis occurs in response to specific cues present in urine and requires excess L-glutamine. J Bacteriol. 2013;195:1305-19 pubmed publisher
    ..We thus conclude that initiation of swarming occurs in response to specific cues and that manipulating concentrations of key nutrient cues can signal whether or not a particular environment is permissive for swarming...
  79. Nagano N, Shibata N, Saitou Y, Nagano Y, Arakawa Y. Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase. J Clin Microbiol. 2003;41:5530-6 pubmed
    ..mirabilis, would be the most effective measures to cope with further spread of this kind of hazardous microorganism in clinical environments...
  80. Khan A, Musharraf A. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection. Med Sci Monit. 2004;10:CR598-602 pubmed
    ..We initiated this study to learn the drug resistance pattern and its location (genomic or plasmid-borne) among the strains of Proteus mirabilis, one of the most common causative agents of urinary tract infection (UTI)...
  81. Claassen D, Batsis J, Orenstein R. Proteus mirabilis: a rare cause of infectious endocarditis. Scand J Infect Dis. 2007;39:373-5 pubmed
    ..We present a case of a 58-y-old female with fevers, bacteremia, and embolic phenomenon. Unlike previous cases, early antibiotic treatment precluded valvular repair or death, leading to a favorable outcome...
  82. Zamankhan Malayeri H, Jamshidi S, Zahraei Salehi T. Identification and antimicrobial susceptibility patterns of bacteria causing otitis externa in dogs. Vet Res Commun. 2010;34:435-44 pubmed publisher
    ..However, in complicated or refractory cases, antimicrobials should be selected based on bacterial culture and antimicrobial susceptibility test...
  83. Scavone P, Rial A, Umpierrez A, Chabalgoity A, Zunino P. Effects of the administration of cholera toxin as a mucosal adjuvant on the immune and protective response induced by Proteus mirabilis MrpA fimbrial protein in the urinary tract. Microbiol Immunol. 2009;53:233-40 pubmed
    ..Further studies are necessary to understand immune modulation in the urinary tract...
  84. Sheiner E, Mazor Drey E, Levy A. Asymptomatic bacteriuria during pregnancy. J Matern Fetal Neonatal Med. 2009;22:423-7 pubmed publisher
    ..Our study was also designed to characterize common bacteria and risk factors associated with asymptomatic bacteriuria during pregnancy...
  85. Nastro M, Montoto Piazza L, Saposnik E, Garcia S, Barberis C, Vay C, et al. [Resistance to extended-spectrum cephalosporins in non-inducible AmpC enterobacteria: evaluation of the new MIC breakpoints]. Rev Argent Microbiol. 2012;44:30-5 pubmed publisher
    ..Regarding the plasmid-mediated AmpC producers, the recommendations of the CLSI 2010 and the EUCAST 2010 proved to be more efficient than the old ones...
  86. Vourli S, Tsorlini H, Katsifa H, Polemis M, Tzouvelekis L, Kontodimou A, et al. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene. Clin Microbiol Infect. 2006;12:691-4 pubmed
    ..This is the first description of the bla(VIM-1) metallo-beta-lactamase gene in P. mirabilis...
  87. Mathoera R, Kok D, Verduin C, Nijman R. Pathological and therapeutic significance of cellular invasion by Proteus mirabilis in an enterocystoplasty infection stone model. Infect Immun. 2002;70:7022-32 pubmed
    ..Bacterial invasion seems to have cell type-dependent mechanisms and prolong bacterial survival in antibiotic therapy, giving a new target for therapeutic optimalization of antibiotic treatment...
  88. Crémet L, Bemer P, Rome J, Juvin M, Navas D, Bourigault C, et al. Outbreak caused by Proteus mirabilis isolates producing weakly expressed TEM-derived extended-spectrum ?-lactamase in spinal cord injury patients with recurrent bacteriuria. Scand J Infect Dis. 2011;43:957-61 pubmed publisher
    ..In such patients, ESBL detection in daily practice should be improved by systematic use of a synergy test in strains of P. mirabilis resistant to penicillins...
  89. Ciappetta P, Calace A, D Urso P, De Candia N. Endoscopic treatment of pituitary abscess: two case reports and literature review. Neurosurg Rev. 2008;31:237-46; discussion 246 pubmed
    ..We recommend early management by endoscopic transphenoidal surgery for pituitary abscess: this technique is safe, with minimal blood loss, short operating time, low morbidity, and brief hospital stay...
  90. Zong Z, Partridge S, Iredell J. RmtC 16S rRNA methyltransferase in Australia. Antimicrob Agents Chemother. 2008;52:794-5 pubmed
  91. Phan V, Belas R, Gilmore B, Ceri H. ZapA, a virulence factor in a rat model of Proteus mirabilis-induced acute and chronic prostatitis. Infect Immun. 2008;76:4859-64 pubmed publisher
    ..Clearance from the prostate was not the result of a reduced capacity of the ZapA(-) mutant to form biofilms in vitro. These finding clearly define ZapA as an important virulence factor in both acute and chronic bacterial prostatitis...